ILÚM Insight im Vergleich zu GeriKit Nutzung und Statistiken

ILÚM Insight®, created by Infectious Disease Connect, is a specialized solution that focuses on the unique challenges of managing infectious disease with the goal of supporting improved patient health and outcomes. ILÚM Insight® is designed to support clinicians as they work to identify and manage infectious disease patients in the hospital setting and manage quality programs such as those for antimicrobial stewardship (ASP). ILÚM Insight® keeps clinicians connected to the latest patient health information and supports patient management decisions and quality programs through: Predictive intelligence capabilities that help improve antibiotic prescribing through patient-specific antibiograms predicting the likelihood of organism susceptibility within each patient. Maintaining a longitudinal patient record and tracking patient-specific risk factors, laboratory results, and epidemiology. Delivering actionable clinical decision support detecting high-risk patients and opportunities for intervention based on institution-specific quality and safety goals. Tracking population outcomes and enabling a continuous quality improvement cycle. Providing alerts to clinicians to identify and act on stewardship opportunities quickly Flexibility to allow the ASP team to utilize provided template stewardship alerts or create site-specific alerts to meet local ASP goals Optimizing communication between the ASP team and clinicians directly from the platform, including a tracking feature for completed communications Streamlining and automates the Infectious Diseases (ID)/ASP approval process for restricted antimicrobials with the utilization of mobile devices and web-based solutions Confirming the clinician’s decision or provides alternate choices based on individualized Precision Antibiotictherapy (PAT) predictions Real-time antibiogram updates ILUM Insight® brings patients that need attention the most to the forefront Download ILUM Insight® and see improved patient outcomes.